madman
Super Moderator
In recent years, the landscape of testosterone replacement therapy (TRT) has evolved significantly, offering new hope for hypogonadal men seeking effective and convenient treatment options. The introduction of oral testosterone undecanoate (TU) marks a pivotal advancement in this field, as highlighted in the comprehensive review by Dr. Julian Borges. This editorial aims to explore the implications of these findings and the future of oral TRT in clinical practice.
* Overview
* A New Era in Testosterone Therapy
* Challenges and Opportunities
* Safety and Efficacy: A Balanced Perspective
* A Step Forward
* Overcoming the Limitations
* Safety and Efficacy
Dr. Julian Borges, MD, holds board certifications in both Endocrinology (SBEM/AMB/CFM) and Clinical Nutrition (ABRA/AMB/CFM). He is renowned for his contributions to science and his expertise in managing complex medical conditions. As a professor of medicine and a clinical investigator, Dr. Borges significantly contributes to the field through both teaching and research. His research interests are broad and impactful, encompassing areas such as cardio-endocrinology, nutro-genomics, precision medicine, and digital health.
* Overview
* A New Era in Testosterone Therapy
* Challenges and Opportunities
* Safety and Efficacy: A Balanced Perspective
* A Step Forward
* Overcoming the Limitations
* Safety and Efficacy
Dr. Julian Borges, MD, holds board certifications in both Endocrinology (SBEM/AMB/CFM) and Clinical Nutrition (ABRA/AMB/CFM). He is renowned for his contributions to science and his expertise in managing complex medical conditions. As a professor of medicine and a clinical investigator, Dr. Borges significantly contributes to the field through both teaching and research. His research interests are broad and impactful, encompassing areas such as cardio-endocrinology, nutro-genomics, precision medicine, and digital health.
